Item 7.01 Regulation FD Disclosure.
Since
The Company believes its long-term fundamentals remain excellent, given its innovative product portfolio and pipeline, strong clinical support, large addressable market, talented global team, and strong cash position. The Company remains dedicated to advancing the health and well-being of its employees and customers, and most importantly, of the patients being treated with its products.
The information contained in Item 7.01 of this Current Report on Form 8-K shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, regardless of any general incorporation language in such filing.
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS
This Current Report on Form 8-K contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. In some cases, you can identify these statements by forward-looking words such as "may," "might," "will," "should," "expects," "plans," "anticipates," "believes," "estimates," "predicts," "potential" or "continue," the negative of these terms and other comparable terminology. These forward-looking statements are only predictions based on our current expectations and projections about future events.
There are important factors that could cause our actual results, level of
activity, performance or achievements to differ materially from the results,
level of activity, performance or achievements expressed or implied by the
forward-looking statements, including, but not limited to: (i) our ability to
design, develop, manufacture and market innovative products to treat patients
with challenging medical conditions, particularly in peripheral artery disease,
coronary artery disease and aortic stenosis; (ii) our expected future growth,
including growth in international sales; (iii) the size and growth potential of
the markets for our products, and our ability to serve those markets; (iv) the
rate and degree of market acceptance of our products; (v) coverage and
reimbursement for procedures performed using our products; (vi) the performance
of third parties in connection with the development of our products, including
third-party suppliers; (vii) regulatory developments in
For a further list and description of other important risks and uncertainties
that may affect our future operations, see Part I, Item IA - Risk Factors in our
most recent Annual Report on Form 10-K filed with the
© Edgar Online, source